Metabolism of paclitaxel in mice

Anti-Cancer Drugs

Volumn 14, Issue 3, 2003, Pages 203-209

  Bardelmeijer, Heleen A ^a   Oomen, Ingrid A M ^a   Hillebrand, Michel J X ^a   Beijnen, Jos H ^a   Schellens, Jan H M ^a   Van Tellingen, Olaf ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

High performance liquid chromatography; Mass spectrometry; Metabolism; Mice; Paclitaxel

Indexed keywords

10 DEACETYLBACCATIN III; 10 DEACETYLPACLITAXEL; 19 HYDROXYPACLITAXEL; 2 HYDROXY 4 DEACETYLPACLITAXEL; 2 HYDROXYPACLITAXEL; 3' HYDROXYPACLITAXEL; 3',6ALPHA DIHYDROXYPACLITAXEL; 4 DEACETYLPACLITAXEL; 6ALPHA HYDROXYPACLITAXEL; 7 EPIPACLITAXEL; BACCATIN III; DRUG METABOLITE; ETHER; PACLITAXEL; PACLITAXEL DERIVATIVE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG EXCRETION; DRUG IDENTIFICATION; DRUG METABOLISM; DRUG STRUCTURE; DRUG URINE LEVEL; FECES ANALYSIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; LIPOPHILICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; TANDEM MASS SPECTROMETRY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FECES; FEMALE; INJECTIONS, INTRAVENOUS; MASS SPECTROMETRY; MICE; PACLITAXEL; TAXOIDS; TRITIUM;

EID: 0037357897     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200303000-00003     Document Type: Article

References (21)

1. Huizing MT, Misser VH, Pieters RC, ten Bokkel Huinink WW, Veenhof CH, Vermorken JB, et al. Taxanes: a new Class of antitumor agents. Cancer Invest 1995; 13:381-404.
2. Rowinsky EK, Donehower RC. Paclitaxel (Taxol). N Engl J Med 1995; 332:1004-1014.
3. Monsarrat B, Mariel E, Cros S, Gares M, Guenard D, Gueritte-Voegelein F, et al. Taxol metabolism. Isolation and identification of three major metabolites of taxol in rat bile. Drug Metab Dispos 1990; 18:895-901.
4. Walle T, Walle UK, Kumar GN, Bhalla KN. Taxol metabolism and disposition in cancer patients. Drug Metab Dispos 1995; 23:506-512.
5. Malingre MM, Schellens JH, van Tellingen O, Rosing H, Koopman FJ, Duchin K, et al. Metabolism and excretion of paclitaxel after oral administration in combination with cyclosporin A and after i.v. administration [In process citation]. Anti-Cancer Drugs 2000; 11:813-820.
6. Monsarrat B, Alvinerie P, Wright M, Dubois J, Gueritte-Voegelein F, Guenard D, et al. Hepatic metabolism and biliary excretion of Taxol in rats and humans. J Natl Cancer Inst Monogr 1993; 39-46.
7. 3H]taxol in the Sprague-Dawley rat. Drug Metab Dispos 1994; 22:254-258.
8. Walle T, Kumar GN, McMillan JM, Thornburg KR, Walle UK. Taxol metabolism in rat hepatocytes. Biochem Pharmacol 1993; 46:1661-1664.
9. Jamis-Dow CA, Klecker RW, Katki AG, Collins JM. Metabolism of taxol by human and rat liver in vitro: a screen for drug interactions and interspecies differences. Cancer Chemother Pharmacol 1995; 36:107-114.
10. Anderson CD, Wang J, Kumar GN, McMillan JM, Walle UK, Walle T. Dexamethasone induction of taxol metabolism in the rat. Drug Metab Dispos 1995; 23:1286-1290.
11. Royer I, Alvinerie P, Armand JP, Ho LK, Wright M, Monsarrat B. Paclitaxel metabolites in human plasma and urine: identification of 6 alpha-hydroxytaxol, 7-epitaxol and taxol hydrolysis products using liquid chromatography/atmospheric-pressure chemical ionization mass spectrometry. Rapid Commun Mass Spectrom 1995; 9:495-502.
12. Monsarrat B, Chatelut E, Royer I, Alvinerie P, Dubois J, Dezeuse A, et al. Modification of paclitaxel metabolism in a cancer patient by induction of cytochrome P450 3A4. Drug Metab Dispos 1998; 26:229-233.
13. Cresteil T, Monsarrat B, Alvinerie P, Treluyer JM, Vieira I, Wright M. Taxol metabolism by human liver microsomes: identification of cytochrome P450 isozymes involved in its biotransformation. Cancer Res 1994; 54:386-392.
14. Harris JW, Rahman A, Kim BR, Guengerich FP, Collins JM. Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme. Cancer Res 1994; 54:4026-4035.
15. Rahman A, Korzekwa KR, Grogan J, Gonzalez FJ, Harris JW. Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8. Cancer Res 1994; 54:5543-5546.
16. Kumar GN, Walle UK, Walle T. Cytochrome P450 3A-mediated human liver microsomal taxol 6 alpha-hydroxylation. J Pharmacol Exp Ther 1994; 268:1160-1165.
17. Sonnichsen DS, Liu Q, Schuetz EG, Schuetz JD, Pappo A, Relling MV. Variability in human cytochrome P450 paclitaxel metabolism. J Pharmacol Exp Ther 1995; 275:566-575.
18. Desai PB, Duan JZ, Zhu YW, Kouzi S. Human liver microsomal metabolism of paclitaxel and drug interactions. Eur J Drug Metab Pharmacokinet 1998; 23:417-424.
19. Sparreboom A, van Tellingen O, Nooijen WJ, Beijnen JH. Determination of paclitaxel and metabolites in mouse plasma, tissues, urine and faeces by semi-automated reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Appl 1995; 664:383-391.
20. Sparreboom A, Huizing MT, Boesen JJ, Nooijen WJ, van Tellingen O, Beijnen JH. Isolation, purification, and biological activity of mono- and dihydroxylated paclitaxel metabolites from human feces. Cancer Chemother Pharmacol 1995; 36:299-304.
21. Schinkel AH, Mayer U, Wagenaar E, Mol CA, van Deemter L, Smit JJ, et al. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA 1997; 94:4028-4033.